Status:
COMPLETED
Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures
Lead Sponsor:
Pathfinder Therapeutics
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study was designed in two phases: Phase I is designed to confirm that the surgeon is able to perform accurate liver surface registration including standard liver features used as landmarks during...
Detailed Description
The Pathfinder System used during this study is used for data collection purposes only and is not used during the surgical procedure as an image guided system. Preoperative computed tomography (CT) s...
Eligibility Criteria
Inclusion
- Scheduled for laparoscopic liver ablation procedure
- Had a preoperative CT image that includes the liver
Exclusion
- Severe cirrhosis of the liver
- Kidney failure or dialysis
- Unable to consent
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01238666
Start Date
November 1 2010
End Date
March 1 2012
Last Update
March 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence Portland Medical Center
Portland, Oregon, United States, 97213